Global Meningococcal Conjugate Market Size, Status and Forecast 2018-2025

Publisher Name :
Date: 29-Oct-2018
No. of pages: 97
Inquire Before Buying

This report focuses on the global Meningococcal Conjugate status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Meningococcal Conjugate development in United States, Europe and China.

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.

In 2017, the global Meningococcal Conjugate market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

- Sanofi Pasteur

- Pfizer

- Glaxo Smith Kline

- Hualan Biological Engineering

- JN International Medical Corporation

- Baxter International

- Merck

- Serum Institute of India

- Biomed

- Novartis

Market segment by Type, the product can be split into

- Menactra

- Menveo

- NeisVac-C

- Nimenrix

- Others

Market segment by Application, split into

- Children

- Preteens or Teens

- Adults

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Meningococcal Conjugate status, future forecast, growth opportunity, key market and key players.

- To present the Meningococcal Conjugate development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Meningococcal Conjugate are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Meningococcal Conjugate Market Size, Status and Forecast 2018-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Meningococcal Conjugate Market Size Growth Rate by Type (2013-2025)
1.4.2 Menactra
1.4.3 Menveo
1.4.4 NeisVac-C
1.4.5 Nimenrix
1.4.6 Others
1.5 Market by Application
1.5.1 Global Meningococcal Conjugate Market Share by Application (2013-2025)
1.5.2 Children
1.5.3 Preteens or Teens
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Meningococcal Conjugate Market Size
2.2 Meningococcal Conjugate Growth Trends by Regions
2.2.1 Meningococcal Conjugate Market Size by Regions (2013-2025)
2.2.2 Meningococcal Conjugate Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Meningococcal Conjugate Market Size by Manufacturers
3.1.1 Global Meningococcal Conjugate Revenue by Manufacturers (2013-2018)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Conjugate Key Players Head office and Area Served
3.3 Key Players Meningococcal Conjugate Product/Solution/Service
3.4 Date of Enter into Meningococcal Conjugate Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Meningococcal Conjugate Market Size by Type (2013-2018)
4.2 Global Meningococcal Conjugate Market Size by Application (2013-2018)
5 United States
5.1 United States Meningococcal Conjugate Market Size (2013-2018)
5.2 Meningococcal Conjugate Key Players in United States
5.3 United States Meningococcal Conjugate Market Size by Type
5.4 United States Meningococcal Conjugate Market Size by Application
6 Europe
6.1 Europe Meningococcal Conjugate Market Size (2013-2018)
6.2 Meningococcal Conjugate Key Players in Europe
6.3 Europe Meningococcal Conjugate Market Size by Type
6.4 Europe Meningococcal Conjugate Market Size by Application
7 China
7.1 China Meningococcal Conjugate Market Size (2013-2018)
7.2 Meningococcal Conjugate Key Players in China
7.3 China Meningococcal Conjugate Market Size by Type
7.4 China Meningococcal Conjugate Market Size by Application
8 Japan
8.1 Japan Meningococcal Conjugate Market Size (2013-2018)
8.2 Meningococcal Conjugate Key Players in Japan
8.3 Japan Meningococcal Conjugate Market Size by Type
8.4 Japan Meningococcal Conjugate Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Meningococcal Conjugate Market Size (2013-2018)
9.2 Meningococcal Conjugate Key Players in Southeast Asia
9.3 Southeast Asia Meningococcal Conjugate Market Size by Type
9.4 Southeast Asia Meningococcal Conjugate Market Size by Application
10 India
10.1 India Meningococcal Conjugate Market Size (2013-2018)
10.2 Meningococcal Conjugate Key Players in India
10.3 India Meningococcal Conjugate Market Size by Type
10.4 India Meningococcal Conjugate Market Size by Application
11 Central & South America
11.1 Central & South America Meningococcal Conjugate Market Size (2013-2018)
11.2 Meningococcal Conjugate Key Players in Central & South America
11.3 Central & South America Meningococcal Conjugate Market Size by Type
11.4 Central & South America Meningococcal Conjugate Market Size by Application
12 International Players Profiles
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Company Details
12.1.2 Company Description and Business Overview
12.1.3 Meningococcal Conjugate Introduction
12.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2013-2018)
12.1.5 Sanofi Pasteur Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Meningococcal Conjugate Introduction
12.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2013-2018)
12.2.5 Pfizer Recent Development
12.3 Glaxo Smith Kline
12.3.1 Glaxo Smith Kline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Meningococcal Conjugate Introduction
12.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2013-2018)
12.3.5 Glaxo Smith Kline Recent Development
12.4 Hualan Biological Engineering
12.4.1 Hualan Biological Engineering Company Details
12.4.2 Company Description and Business Overview
12.4.3 Meningococcal Conjugate Introduction
12.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2013-2018)
12.4.5 Hualan Biological Engineering Recent Development
12.5 JN International Medical Corporation
12.5.1 JN International Medical Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Meningococcal Conjugate Introduction
12.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2013-2018)
12.5.5 JN International Medical Corporation Recent Development
12.6 Baxter International
12.6.1 Baxter International Company Details
12.6.2 Company Description and Business Overview
12.6.3 Meningococcal Conjugate Introduction
12.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2013-2018)
12.6.5 Baxter International Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Meningococcal Conjugate Introduction
12.7.4 Merck Revenue in Meningococcal Conjugate Business (2013-2018)
12.7.5 Merck Recent Development
12.8 Serum Institute of India
12.8.1 Serum Institute of India Company Details
12.8.2 Company Description and Business Overview
12.8.3 Meningococcal Conjugate Introduction
12.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2013-2018)
12.8.5 Serum Institute of India Recent Development
12.9 Biomed
12.9.1 Biomed Company Details
12.9.2 Company Description and Business Overview
12.9.3 Meningococcal Conjugate Introduction
12.9.4 Biomed Revenue in Meningococcal Conjugate Business (2013-2018)
12.9.5 Biomed Recent Development
12.10 Novartis
12.10.1 Novartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Meningococcal Conjugate Introduction
12.10.4 Novartis Revenue in Meningococcal Conjugate Business (2013-2018)
12.10.5 Novartis Recent Development
13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Meningococcal Conjugate Key Market Segments
Table Key Players Meningococcal Conjugate Covered
Table Global Meningococcal Conjugate Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Meningococcal Conjugate Market Size Market Share by Type 2013-2025
Figure Menactra Figures
Table Key Players of Menactra
Figure Menveo Figures
Table Key Players of Menveo
Figure NeisVac-C Figures
Table Key Players of NeisVac-C
Figure Nimenrix Figures
Table Key Players of Nimenrix
Figure Others Figures
Table Key Players of Others
Table Global Meningococcal Conjugate Market Size Growth by Application 2013-2025 (Million US$)
Figure Children Case Studies
Figure Preteens or Teens Case Studies
Figure Adults Case Studies
Figure Meningococcal Conjugate Report Years Considered
Table Global Meningococcal Conjugate Market Size 2013-2025 (Million US$)
Figure Global Meningococcal Conjugate Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Meningococcal Conjugate Market Size by Regions 2013-2025 (Million US$)
Table Global Meningococcal Conjugate Market Size by Regions 2013-2018 (Million US$)
Table Global Meningococcal Conjugate Market Share by Regions 2013-2018
Figure Global Meningococcal Conjugate Market Share by Regions 2013-2018
Figure Global Meningococcal Conjugate Market Share by Regions 2018
Table Market Top Trends
Table Global Meningococcal Conjugate Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Meningococcal Conjugate Market Share by Manufacturers (2013-2018)
Figure Global Meningococcal Conjugate Market Share by Manufacturers in 2018
Table Global Meningococcal Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Meningococcal Conjugate Product/Solution/Service
Table Date of Enter into Meningococcal Conjugate Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table Global Meningococcal Conjugate Market Size Share by Type (2013-2018)
Figure Global Meningococcal Conjugate Market Size Market Share by Type (2013-2018)
Table Global Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table Global Meningococcal Conjugate Market Size Share by Application (2013-2018)
Figure Global Meningococcal Conjugate Market Size Market Share by Application (2013-2018)
Figure Global Meningococcal Conjugate Revenue Market Share by Application in 2017
Figure United States Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table United States Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table United States Key Players Meningococcal Conjugate Market Share (2017-2018)
Table United States Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table United States Meningococcal Conjugate Market Share by Type (2013-2018)
Table United States Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table United States Meningococcal Conjugate Market Share by Application (2013-2018)
Figure Europe Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table Europe Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table Europe Key Players Meningococcal Conjugate Market Share (2017-2018)
Table Europe Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table Europe Meningococcal Conjugate Market Share by Type (2013-2018)
Table Europe Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table Europe Meningococcal Conjugate Market Share by Application (2013-2018)
Figure China Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table China Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table China Key Players Meningococcal Conjugate Market Share (2017-2018)
Table China Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table China Meningococcal Conjugate Market Share by Type (2013-2018)
Table China Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table China Meningococcal Conjugate Market Share by Application (2013-2018)
Figure Japan Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table Japan Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table Japan Key Players Meningococcal Conjugate Market Share (2017-2018)
Table Japan Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table Japan Meningococcal Conjugate Market Share by Type (2013-2018)
Table Japan Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table Japan Meningococcal Conjugate Market Share by Application (2013-2018)
Figure Southeast Asia Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Meningococcal Conjugate Market Share (2017-2018)
Table Southeast Asia Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Meningococcal Conjugate Market Share by Type (2013-2018)
Table Southeast Asia Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Meningococcal Conjugate Market Share by Application (2013-2018)
Figure India Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table India Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table India Key Players Meningococcal Conjugate Market Share (2017-2018)
Table India Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table India Meningococcal Conjugate Market Share by Type (2013-2018)
Table India Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table India Meningococcal Conjugate Market Share by Application (2013-2018)
Figure Central & South America Meningococcal Conjugate Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Meningococcal Conjugate Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Meningococcal Conjugate Market Share (2017-2018)
Table Central & South America Meningococcal Conjugate Market Size by Type (2013-2018) (Million US$)
Table Central & South America Meningococcal Conjugate Market Share by Type (2013-2018)
Table Central & South America Meningococcal Conjugate Market Size by Application (2013-2018) (Million US$)
Table Central & South America Meningococcal Conjugate Market Share by Application (2013-2018)
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2013-2018) (Million US$)
Figure Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Sanofi Pasteur Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Pfizer Recent Development
Table Glaxo Smith Kline Company Details
Table Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Glaxo Smith Kline Recent Development
Table Hualan Biological Engineering Company Details
Table Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Hualan Biological Engineering Recent Development
Table JN International Medical Corporation Company Details
Table JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table JN International Medical Corporation Recent Development
Table Baxter International Company Details
Table Baxter International Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Baxter International Recent Development
Table Merck Company Details
Table Merck Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Merck Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Merck Recent Development
Table Serum Institute of India Company Details
Table Serum Institute of India Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Serum Institute of India Recent Development
Table Biomed Company Details
Table Biomed Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Biomed Recent Development
Table Novartis Company Details
Table Novartis Revenue in Meningococcal Conjugate Business (2013-2018)(Million US$)
Figure Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2013-2018)
Table Novartis Recent Development
Table Global Meningococcal Conjugate Market Size by Regions (Million US$) 2018-2025
Figure Global Meningococcal Conjugate Market Size Share by Regions (2018-2025)
Figure Global Meningococcal Conjugate Market Size Share by Regions in 2025
Figure United States Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure Europe Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure China Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure Japan Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure India Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Meningococcal Conjugate Market Size Forecast (2018-2025)(Million USD)
Table Global Meningococcal Conjugate Market Size by Product (2018-2025) (Million US$)
Figure Global Meningococcal Conjugate Market Size by Product (2018-2025)
Figure Global Meningococcal Conjugate Market Size by Product in 2025
Table Global Meningococcal Conjugate Market Size by Application (2018-2025) (Million US$)
Figure Global Meningococcal Conjugate Market Size by Application (2018-2025)
Figure Global Meningococcal Conjugate Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • 2021-2027 Global and Regional 23-Valent Pneumococcal Polysaccharide Vaccine Industry Status and Prospects Professional Market Research Report Standard Version
    Published: 13-Sep-2021        Price: US 3500 Onwards        Pages: 140
    The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 1986.07 Million USD in 2020 and will grow with a CAGR of 14.57% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(N......
  • United States Encephalitis Vaccination Market Report & Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Encephalitis Vaccination Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (10K Person-time) United States Encephalitis Vaccination Market Segment Percentages, By Type, 2020 (%) - Encephalitis B Vaccine - Encephalitis Attenuated Live Vaccine United States Encephalitis Vaccination Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (10K Person-time) United States Encephalitis Vaccination Market Segment Percentages, By Application......
  • United States Avian Influenza Vaccines Market Report & Forecast 2021-2027
    Published: 08-Sep-2021        Price: US 3400 Onwards        Pages: 110
    United States Avian Influenza Vaccines Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Avian Influenza Vaccines Market Segment Percentages, By Type, 2020 (%) - H5+H7 Avian Influenza Vaccines - H9 Avian Influenza Vaccines United States Avian Influenza Vaccines Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses) United States Avian Influenza Vaccines Market Segment Percentages, By Application, 2020 (%) ......
  • United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report & Forecast 2021-2027
    Published: 07-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose) United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Type, 2020 (%) - Single Dose Vial - Pre-filled Syringe United States 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Dose) United States 23-Valent Pneumococcal Polysaccharide Vaccine ......
  • Global Meningococcal Conjugate Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 07-Sep-2021        Price: US 3480 Onwards        Pages: 94
    The Meningococcal Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest......
  • Global Avian Influenza Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 03-Sep-2021        Price: US 3480 Onwards        Pages: 108
    The Avian Influenza Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global and Japan Influenza Vaccine Market Insights, Forecast to 2027
    Published: 03-Sep-2021        Price: US 3900 Onwards        Pages: 136
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. Global Influenza Vaccine main players include ......
  • Global and Japan Avian Influenza Vaccines Market Insights, Forecast to 2027
    Published: 02-Sep-2021        Price: US 3900 Onwards        Pages: 161
    Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria. Global Avian Influenza V......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 01-Sep-2021        Price: US 3480 Onwards        Pages: 109
    The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs